Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III a/B Unresectable Non-Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3181d60e8f
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Observation of Docetaxel or Gemcitabine Combined With Cisplatin in the Chemotherapy After Surgery for Stage II-III Non-Small Cell Lung Cancer

West Indian Medical Journal
Medicine
2015English

Randomized Phase II Trial of Paclitaxel and Carboplatin Followed by Gemcitabine Switch-Maintenance Therapy Versus Gemcitabine and Carboplatin Followed by Gemcitabine Continuation-Maintenance Therapy in Previously Untreated Advanced Non-Small Cell Lung Cancer

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2013English

Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2013English

Single Agent Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer. Phase II Study

Research in Oncology
2007English

119P Cisplatin/Etoposide or Paclitaxel/Carboplatin With Concurrent Radiation Therapy in Stage IIIB Non-Small Cell Lung Cancer: A One-Year Phase II Trial at a Low Resource Setting

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Comparison of Toxicity Profile of Gemcitabine Monotherapy Versus Etoposide/Cisplatin in the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer

International Journal of Basic & Clinical Pharmacology
2015English

Refractory Non-Small-Cell Lung Cancer Responding to Combination Chemotherapy With Gemcitabine and Cisplatin

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2003English

Treatment Outcomes of Different Prognostic Groups of Patients on Cancer and Leukemia Group B Trial 39801: Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Unresectable Stage III Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2009English

162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy